RAPT Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
RAPT Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q3 2024.
  • RAPT Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $3.83M, a 32.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.83M -$1.85M -32.6% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $4.3M -$1.8M -29.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $4.77M -$1.75M -26.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $5.23M -$1.71M -24.7% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $5.67M -$110K -1.9% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $6.1M +$48K +0.79% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $6.53M +$204K +3.23% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $6.94M Dec 31, 2022 10-K 2024-03-07
Q3 2022 $5.78M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $6.06M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $6.32M Mar 31, 2022 10-Q 2022-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.